Table 3.

The relationship between tumor response and RNETS groups in patients treated with PD-1 inhibitors.

	high-RNETS (n=83)	low-RNETS (n=54)	P
Treatment line (Immunotherapy)			0.595
First-Line	25 (30.1)	14 (25.9)
Second-Line	58 (69.9)	40 (74.1)
Treatment response
CR	0 (0)	1 (1.9)
PD	37 (44.6)	12 (22.2)
PR	9 (10.8)	14 (25.9)
SD	37 (44.6)	27 (50.0)
ORR(CR+PR)	9 (10.8)	15 (27.8)	0.020
DCR(CR+PR+SD)	46 (55.4)	42 (77.8)	0.013

Variables are expressed as number of patients (%).

CR, complete response; DCR, disease control rate; ORR, objective response rate; PD, progressive disease; PR, partial response; SD, stable disease.